Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Models for angiogenesis in gliomas.

Roland H Goldbrunner1, Martin Bendszus, Jörg-Christian Tonn

  • 1Department of Neurosurgery, Grosshadern Hospital, Ludwig-Maximilians, University of Munich, 81377 Munich, Germany.

Cancer Treatment and Research
|March 16, 2004
PubMed
Summary

Researchers explored various models for studying glioma vascularization and anti-angiogenic therapies. Selecting the appropriate model, from in vitro assays to in vivo animal studies, is crucial for valid research outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contemporary surgical strategies for resection of intracranial gliomas.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Stereotactically Guided Microsurgical Approach for Deep-Seated Eloquently Located Lesions.

Journal of clinical medicine·2025
Same author

The inconsistent terminology for the extent of resection in glioblastoma: A systematic review on 6 decades of neuro-oncological studies.

Neuro-oncology·2024
Same author

Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort study.

The Lancet. Oncology·2024
Same author

Injury-specific factors in the cerebrospinal fluid regulate astrocyte plasticity in the human brain.

Nature medicine·2023
Same author

Neurosurgical Interventions for Cerebral Metastases of Solid Tumors.

Deutsches Arzteblatt international·2023

Area of Science:

  • Oncology
  • Vascular Biology
  • Biomedical Engineering

Background:

  • Significant research has focused on glioma vascularization mechanisms, including growth factors and receptors.
  • Anti-angiogenic treatment strategies for gliomas are being developed using various in vitro and in vivo models.
  • Preclinical trials necessitate a diverse range of models to address complex research questions.

Purpose of the Study:

  • To review and discuss the suitability of different experimental models for studying glioma vascularization and anti-angiogenic therapies.
  • To highlight the importance of selecting appropriate models that mimic crucial tumor-host interactions.
  • To emphasize the need for understanding model limitations for effective research design.

Main Methods:

  • In vitro endothelial cell (EC) monolayer assays for basic EC characteristics.

Related Experiment Videos

  • Three-dimensional spheroid techniques for cell-cell and cell-environment interactions.
  • Molecular genetic techniques (microarray/chip) for assessing EC gene expression.
  • Animal models, including orthotopic and syngeneic models, for tumor-host interactions.
  • Human glioma xenografting into immunocompromised animals.
  • In vivo monitoring techniques (videoscopy, MRI) for functional studies.

    • Main Results:

    • In vitro models are suitable for basic EC characteristics, while 3D spheroids offer more complex interactions.
    • Molecular techniques allow detailed analysis of EC gene expression.
    • Orthotopic animal models are essential for studying organ-specific tumor-host interactions.
    • Syngeneic models minimize allo-immunogenic responses, but rat gliomas may not accurately reflect human growth.
    • Human glioma xenografts in immunocompromised animals are a viable alternative.
    • In vivo monitoring enhances the validity and functional assessment of experimental models.

    Conclusions:

    • A variety of models exist for studying glioma vascularization, each with specific strengths and limitations.
    • The choice of model should be tailored to the specific research objectives, considering factors like tumor-host interaction and immunogenicity.
    • Recognizing the limitations of each model is paramount for the validity and successful application of research findings in anti-angiogenic therapy development.